Investor Relations

Tekmira is a leader in the development of therapeutic agents based upon Nobel Prize winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi). Tekmira's three lead RNAi product candidates target cholesterol management, cancer and Ebola infection. In addition to its pipeline of products, Tekmira also has collaborative partnerships with leading companies in the RNAi field.

Site Map Copyright©2008 Tekmira Pharmaceuticals Corp. All rights reserved. See legal terms for use of site.